InvestorsHub Logo
Followers 86
Posts 12714
Boards Moderated 0
Alias Born 10/12/2010

Re: eb0783 post# 273300

Sunday, 09/25/2016 9:03:56 AM

Sunday, September 25, 2016 9:03:56 AM

Post# of 345752
Here is a list of the MRFBC sites (Wistar included..) and Dr Wolchok a founding member....so possibly bringing in PS Targeting to combos for future Melanoma trials
https://www.melanoma.org/sites/default/files/MRFBCBrochureUpdated.pdf

"Bavituximab is a first-in-class phosphatidylserine (PS)-targeting monoclonal antibody that is the cornerstone of a broad clinical
pipeline."
-- Big Pharmas nightmare... unless they are fortunate enough to have The Bavi Edge!

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CDMO News